申请人:Benedini Francesca
公开号:US20080318965A1
公开(公告)日:2008-12-25
The present invention relates to alpha
2
-adrenergic receptor agonist nitrooxyderivatives having improved pharmacological activity and enhanced tolerability. They can be employed for the treatment of ocular diseases, in particular high intraocular pressure and glaucoma.